Table 1.

Schedule of Trial Events

Study Procedures	Screening	IRE	Post-IRE 1-2wk FUP	Last Day RT	3,6,9-mo FUP	12-mo FUP	24-mo FUP
Informed Consent	X
Demographics/ MH	X
Physical Exam	X		X	X	X	X	X
VS, Height, weight	X		X	X	X	X	X
PSA	X				X	X	X
Pelvic MRI	X*					X
PSMA PET	X*					X
EPIC-CP	X			X	X	X	X
IPSS	X			X	X	X	X
IIEF-5	X			X	X	X	X
Tissue Biopsy (Research)		X
Research samples (Blood, Urine)	X			X		X
Adverse Events (CTCAE v5.0)	X	X	X	X	X	X	X
Post-Treatment Biopsy (+/- 1 month)	X					X

*Imaging completed ≤ 9 months acceptable for enrollment

IRE Irreversible electroporation, FUP follow up visit, mo months, MH medical history, PSMA PET prostate-specific membrane antigen positron emission tomography, EPIC-CP Expanded PCa Index Composite for Clinical Practice, IPSS International Prostate Symptom Score, CTCAE v5.0 Common Terminology Criteria for Adverse Events version 5.0